An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer
Clinical trial NCT07444281 · RECRUITING
Trial details
- NCT number
- NCT07444281
- Sponsor
- Shanghai AbelZeta Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-25
- Primary completion
- 2027-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.